These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25662072)

  • 1. Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.
    Zhang X; Li Y; Cheng Y; Tan H; Li Z; Qu Y; Mu G; Wang F
    Biochim Biophys Acta; 2015 Jun; 1850(6):1140-9. PubMed ID: 25662072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
    Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
    Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis.
    Pan X; Wang Y; Zhang M; Pan W; Qi ZT; Cao GW
    World J Gastroenterol; 2004 May; 10(10):1409-14. PubMed ID: 15133844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
    Tan H; Mu G; Zhu W; Liu J; Wang F
    Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental choroidal neovascularization is inhibited by subretinal administration of Endostatin].
    Shang QL; Ma JX; Wei JS; Shang ZL; Xiu HM; Yang AQ
    Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):266-71. PubMed ID: 15268837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
    Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
    Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
    Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous endostatin inhibits choroidal neovascularization.
    Marneros AG; She H; Zambarakji H; Hashizume H; Connolly EJ; Kim I; Gragoudas ES; Miller JW; Olsen BR
    FASEB J; 2007 Dec; 21(14):3809-18. PubMed ID: 17526870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
    Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
    Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin.
    Ning TH; Chao CJ; Ying MG; Min X; Shan WF
    Pharmazie; 2012 Jul; 67(7):622-7. PubMed ID: 22888520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of HM-3 after intravitreal administration in mice.
    Yuan D; Shen H; Yuan S; Liu X; Xia X; Xie P; Li W; Hu J; Liu Q; Xu H
    Curr Eye Res; 2014 Aug; 39(8):837-44. PubMed ID: 24559456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.
    Sheibani N; Wang S; Darjatmoko SR; Fisk DL; Shahi PK; Pattnaik BR; Sorenson CM; Bhowmick R; Volpert OV; Albert DM; Melgar-Asensio I; Henkin J
    Exp Eye Res; 2019 Nov; 188():107798. PubMed ID: 31520600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo.
    Hai-Tao Z; Hui-Cheng L; Zheng-Wu L; Chang-Hong G
    Anticancer Drugs; 2011 Jun; 22(5):409-15. PubMed ID: 21427563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
    Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
    Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of human endostatin from Hansenula polymorpha A16.
    Wu J; Fu W; Luo J; Zhang T
    Protein Expr Purif; 2005 Jul; 42(1):12-9. PubMed ID: 15939289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration.
    Tatar O; Shinoda K; Adam A; Rohrbach JM; Lucke K; Henke-Fahle S; Bartz-Schmidt KU; Grisanti S
    Exp Eye Res; 2006 Aug; 83(2):329-38. PubMed ID: 16584730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
    Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.